Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02346929 · ClinicalTrials.gov registry record · NA

Hematoma Block for Distal Radius Fracture

A NA study of Distal Radius Fracture, sponsored by Beth Israel Deaconess Medical Center.

Recruiting
Registry status
NA
Development phase
115
Enrollment target
1
Study location

NCT02346929: Recruiting NA study of Distal Radius Fracture, sponsored by Beth Israel Deaconess Medical Center.

NCT02346929 is a NA study of Distal Radius Fracture that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 115 participants, below the 242-participant average among 11 other Distal Radius Fracture trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02346929, a NA study of Distal Radius Fracture, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.

RECRUITING
Registry status
NA
Development phase
115 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the efficacy of ultrasound guided hematoma block versus traditional "blind" hematoma block for analgesia in distal radius fracture reduction.

Primary Outcome

Subjects will be surveyed on a Visual Analog Scale (VAS) on their pain during 4 points: prior to receiving hematoma block, after receiving hematoma block, during reduction and prior to discharge

Conditions Studied

Interventions

  • OTHER ultrasound guide

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2014-08
Est. Completion 2027-12
Phase NA

What NCT02346929 shows while recruiting

NCT02346929 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 242-participant average among 11 other Distal Radius Fracture trials with a reported enrollment target (52% lower).

The record links to 1 condition, with Distal Radius Fracture appearing as the primary indexed condition, and to 1 intervention - of which ultrasound guide is the first listed.

NCT02346929 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02346929 about?

NCT02346929 is a clinical study titled "Hematoma Block for Distal Radius Fracture". The purpose of this study is to determine the efficacy of ultrasound guided hematoma block versus traditional "blind" hematoma block for analgesia in distal radius fracture reduction.

What is the current status of trial NCT02346929?

This trial is currently recruiting. It is a NA study. The enrollment target is 115 participants. The study started on 2014-08. Estimated completion is 2027-12.

What conditions does trial NCT02346929 study?

This clinical trial studies the following conditions: Distal Radius Fracture.

What interventions are being tested in trial NCT02346929?

The interventions under investigation include: ultrasound guide (OTHER).

Who is sponsoring clinical trial NCT02346929?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02346929 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Distal Radius Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02346929's enrollment target sits among peer trials

115 7th of 11 higher than 5 of 11 other Distal Radius Fracture trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Distal Radius Fracture trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03394365 · 115 participants · Phase 3

    A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

  • NCT03907475 · 115 participants · Phase 2

    Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

  • NCT05086692 · 115 participants · Phase 1

    A Beta-only IL-2 ImmunoTherapY Study

  • NCT05167786 · 115 participants · NA

    Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02346929, the US trial registry maintained by the National Library of Medicine. NCT02346929 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.